{
    "id": "35bb6a29-1c58-f8b1-e063-6394a90a7376",
    "indications": "mupirocin ointment usp , 2 % indicated topical treatment impetigo due susceptible isolates staphylococcus aureus ( s. aureus ) streptococcus pyogenes ( s. pyogenes ) .",
    "contraindications": "• topical . • apply small amount mupirocin ointment , cotton swab gauze pad , affected area 3 times daily 10 days . • cover treated area gauze dressing desired . • re-evaluate patients showing response within 3 5 days . • mupirocin ointment intranasal , ophthalmic , mucosal [ ( 5.2 , 5.6 ) ] . • apply mupirocin ointment concurrently lotions , creams , ointments [ pharmacology ( 12.3 ) ] .",
    "warningsAndPrecautions": "gram mupirocin ointment usp , 2 % contains 20 mg mupirocin , usp water-miscible ointment base . mupirocin ointment usp , 2 % supplied follows : ndc 21922-073-04 ( 15-gram tube ) ndc 21922-073-25 ( 22-gram tube ) ndc 21922-073-05 ( 30-gram tube ) store 20°c 25°c ( 68°f 77°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "mupirocin ointment contraindicated patients known hypersensitivity mupirocin excipients mupirocin ointment .",
    "ingredients": [
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "MUPIROCIN",
            "code": "D0GX863OA5"
        }
    ],
    "organization": "Encube Ethicals Private Limited",
    "name": "MUPIROCIN",
    "effectiveTime": "20250522",
    "indications_original": "Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of\n \n  Staphylococcus aureus\n                     (S. aureus)and\n \n  Streptococcus pyogenes\n                     (S. pyogenes).",
    "contraindications_original": "• For Topical Use Only. \n    • Apply a small amount of mupirocin ointment, with a cotton swab or gauze pad, to the affected area 3 times daily for up to 10 days. \n    • Cover the treated area with gauze dressing if desired. \n    • Re-evaluate patients not showing a clinical response within 3 to 5 days. \n    • Mupirocin ointment is not for intranasal, ophthalmic, or other mucosal use [\n \n  see Warnings and Precautions (\n  \n   5.2,\n  \n   5.6)\n \n  ]. \n    • Do not apply mupirocin ointment concurrently with any other lotions, creams, or ointments [\n \n  see Clinical Pharmacology (\n  \n   12.3)\n \n  ].",
    "warningsAndPrecautions_original": "Each gram of Mupirocin Ointment USP, 2% contains 20 mg mupirocin, USP in a water-miscible ointment base.\n                  Mupirocin Ointment USP, 2% is supplied as follows:\n                  \n                  NDC 21922-073-04 (15-gram tube) \n    NDC 21922-073-25 (22-gram tube) \n    NDC 21922-073-05 (30-gram tube)\n \n                  \n                  \n                  Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature].",
    "adverseReactions_original": "Mupirocin ointment is contraindicated in patients with known hypersensitivity to mupirocin or any of the excipients of mupirocin ointment."
}